Synergistic effect of curcumin and cisplatin via down-regulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1)

Molecular Pharmacology

Volumn 80, Issue 1, 2011, Pages 136-146

  Tsai, Min Shao ^a   Weng, Shao Hsing ^a   Kuo, Ya Hsun ^a   Chiu, Yu Fan ^a   Lin, Yun Wei ^a  

^a NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CISPLATIN; CURCUMIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; LACTACYSTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; THYMIDINE PHOSPHORYLASE;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; CISPLATIN; CURCUMIN; DNA PRIMERS; DNA-BINDING PROTEINS; DOWN-REGULATION; DRUG SYNERGISM; ENDONUCLEASES; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; THYMIDINE PHOSPHORYLASE;

EID: 79959321665     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.071316     Document Type: Article

References (38)

1. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, and Price JE (2005) Curcumin suppresses the paclitaxel-induced nuclear factorkappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11:7490-7498. (Pubitemid 41507710)
2. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, and Aggarwal BB (2006) Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69:195-206. (Pubitemid 43048906)
3. Altaha R, Liang X, Yu JJ, and Reed E (2004) Excision repair cross complementinggroup 1: gene expression and platinum resistance. Int J Mol Med 14:959-970.
4. Azuma K, Komohara Y, Sasada T, Terazaki Y, Ikeda J, Hoshino T, Itoh K, Yamada A, and Aizawa H (2007) Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Sci 98:1336-1343. (Pubitemid 47241754)
5. Basu A and Tu H (2005) Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta. Biochem Biophys Res Commun 334:1068-1073. (Pubitemid 41074683)
6. Bava SV, Puliappadamba VT, Deepti A, Nair A, Karunagaran D, and Anto RJ (2005) Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization. J Biol Chem 280:6301-6308. (Pubitemid 40341176)
7. Chen YR and Tan TH (1998) Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17:173-178.
8. Chirnomas D, Taniguchi T, de la Vega M, Vaidya AP, Vasserman M, Hartman AR, Kennedy R, Foster R, Mahoney J, Seiden MV, et al. (2006) Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol Cancer Ther 5:952-961. (Pubitemid 43724595)
9. Deeb D, Jiang H, Gao X, Hafner MS, Wong H, Divine G, Chapman RA, Dulchavsky SA, and Gautam SC (2004) Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol Cancer Ther 3:803-812. (Pubitemid 39193762)
10. Dhandapani KM, Mahesh VB, and Brann DW (2007) Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102:522-538. (Pubitemid 47000605)
11. Dorai T, Cao YC, Dorai B, Buttyan R, and Katz AE (2001) Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47:293-303.
12. Du B, Jiang L, Xia Q, and Zhong L (2006) Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy 52:23-28. (Pubitemid 43004433)
13. Furuta T, Ueda T, Aune G, Sarasin A, Kraemer KH, and Pommier Y (2002) Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Res 62:4899-4902. (Pubitemid 34984411)
14. Han SS, Keum YS, Seo HJ, and Surh YJ (2002) Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35:337-342.
15. Hsu DS, Lan HY, Huang CH, Tai SK, Chang SY, Tsai TL, Chang CC, Tzeng CH, Wu KJ, Kao JY, et al. (2010) Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. Clin Cancer Res 16:4561-4571.
16. Ikeda R, Furukawa T, Mitsuo R, Noguchi T, Kitazono M, Okumura H, Sumizawa T, Haraguchi M, Che XF, Uchimiya H, et al. (2003) Thymidine phosphorylase inhibits apoptosis induced by cisplatin. Biochem Biophys Res Commun 301:358-363. (Pubitemid 36279246)
17. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, and Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106-130.
18. Jeung HC, Che XF, Haraguchi M, Furukawa T, Zheng CL, Sumizawa T, Rha SY, Roh JK, and Akiyama S (2005) Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. Biochem Pharmacol 70:13-21. (Pubitemid 40797866)
19. Jeung HC, Che XF, Haraguchi M, Zhao HY, Furukawa T, Gotanda T, Zheng CL, Tsuneyoshi K, Sumizawa T, Roh JK, et al. (2006) Protection against DNA damage-induced apoptosis by the angiogenic factor thymidine phosphorylase. FEBS Lett 580:1294-1302. (Pubitemid 43221991)
20. Jung EM, Lim JH, Lee TJ, Park JW, Choi KS, and Kwon TK (2005) Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)- induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26:1905-1913.
21. Ko JC, Su YJ, Lin ST, Jhan JY, Ciou SC, Cheng CM, Chiu YF, Kuo YH, Tsai MS, and Lin YW (2010) Emodin enhances cisplatin-induced cytotoxicity via downregulation of ERCC1 and inactivation of ERK1/2. Lung Cancer 69:155-164.
22. Lev-Ari S, Vexler A, Starr A, Ashkenazy-Voghera M, Greif J, Aderka D, and Ben-Yosef R (2007) Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 25:411-418. (Pubitemid 47450667)
23. Li Q, Gardner K, Zhang L, Tsang B, Bostick-Bruton F, and Reed E (1998) Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells. J Biol Chem 273:23419-23425. (Pubitemid 28417531)
24. Mori K, Hasegawa M, Nishida M, Toma H, Fukuda M, Kubota T, Nagasue N, Yamana H, Hirakawa-Ys Chung K, Ikeda T, et al. (2000) Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 17:33-38.
25. Mori S, Takao S, Ikeda R, Noma H, Mataki Y, Wang X, Akiyama S, and Aikou T (2002) Thymidine phosphorylase suppresses Fas-induced apoptotic signal transduction independent of its enzymatic activity. Biochem Biophys Res Commun 295:300-305. (Pubitemid 34785833)
26. Niedernhofer LJ, Odijk H, Budzowska M, van Drunen E, Maas A, Theil AF, de Wit J, Jaspers NG, Beverloo HB, Hoeijmakers JH, et al. (2004) The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol Cell Biol 24:5776-5787. (Pubitemid 38787963)
27. Ohmichi M, Hayakawa J, Tasaka K, Kurachi H, and Murata Y (2005) Mechanisms of platinum drug resistance. Trends Pharmacol Sci 26:113-116. (Pubitemid 40313588)
28. Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP, and Carrier E (2004) Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208:163-170. (Pubitemid 38624157)
29. Rosell R, Lord RV, Taron M, and Reguart N (2002) DNA repair and cisplatin resistance in non-small-cell lung cancer. Lung Cancer 38:217-227. (Pubitemid 35341796)
30. Rudin CM, Yang Z, Schumaker LM, VanderWeele DJ, Newkirk K, Egorin MJ, Zuhowski EG, and Cullen KJ (2003) Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance. Cancer Res 63:312-318. (Pubitemid 36152486)
31. Schwer CI, Guerrero AM, Humar M, Roesslein M, Goebel U, Stoll P, Geiger KK, Pannen BH, Hoetzel A, and Schmidt R (2008) Heme oxygenase-1 inhibits the proliferation of pancreatic stellate cells by repression of the extracellular signal-regulated kinase1/2 pathway. J Pharmacol Exp Ther 327:863-871.
32. Sève P and Dumontet C (2005) Chemoresistance in non-small cell lung cancer. Curr Med Chem Anticancer Agents 5:73-88. (Pubitemid 40081296)
33. Shishodia S, Sethi G, and Aggarwal BB (2005) Curcumin: getting back to the roots. Ann NY Acad Sci 1056:206-217. (Pubitemid 43030979)
34. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279.
35. Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, and Mori N (2006a) Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. Leuk Res 30:313-321. (Pubitemid 43053227)
36. Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M, Tridandapani S, Anant S, and Kuppusamy P (2007) Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 6:178-184. (Pubitemid 46641620)
37. Woessmann W, Chen X, and Borkhardt A (2002) Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines. Cancer Chemother Pharmacol 50:397-404. (Pubitemid 35446295)
38. Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH, Min DS, Chang JS, Jeong YJ, Lee YH, et al. (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, downregulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24:1199-1208. (Pubitemid 36927060)